External Validation of the FIPS Score for Post-TIPS Mortality in a National Veterans Affairs Cohort
- PMID: 34797445
- PMCID: PMC9117561
- DOI: 10.1007/s10620-021-07307-5
External Validation of the FIPS Score for Post-TIPS Mortality in a National Veterans Affairs Cohort
Abstract
Background: The Freiburg index of post-TIPS survival (FIPS) score was recently demonstrated to improve prediction of post-TIPS mortality relative to existing standards. As this score was derived from a German cohort over an extended time period, it is unclear if performance will translate well to other settings. This study aimed to externally validate the FIPS score in a large Veterans Affairs (VA) cohort over two separate eras of TIPS-related care.
Methods: This was a retrospective cohort study of patients with cirrhosis who underwent TIPS placement in the VA from 2008 to 2020. Cox regression models for post-TIPS survival were constructed using FIPS, MELD, MELD-Na, or CTP scores as predictors. Discrimination (Harrell's C) and calibration (joint tests of calibration curve slope and intercept) were evaluated for each score. A stratified analysis was performed for time periods between 2008-2013 and 2014-2020.
Results: The cohort of 1,274 patients was 97.3% male with mean age 60.9 years and mean MELD-Na 14. The FIPS score demonstrated the highest overall discrimination versus MELD, MELD-Na, and CTP (0.634 vs. 0.585, 0.626, 0.612, respectively). However, in the modern treatment era (2014-2020), the FIPS score performed similarly to MELD-Na. Additionally, the FIPS score demonstrated poor calibration at one-month and six-month post-TIPS timepoints (joint p = 0.04 and 0.004, respectively). MELD, MELD-Na, and CTP were well-calibrated at each timepoint (each joint p > 0.05).
Conclusion: The FIPS score performed similarly to MELD-Na in the modern TIPS treatment era and demonstrated regions of poor calibration. Future models derived with contemporary data may improve prediction of post-TIPS mortality.
Keywords: Cirrhosis; FIPS; MELD-Na; Prediction modeling; TIPS.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Figures


Similar articles
-
FIPS Score for Prediction of Survival After TIPS Placement: External Validation and Comparison With Traditional Risk Scores in a Cohort of Chinese Patients With Cirrhosis.AJR Am J Roentgenol. 2022 Aug;219(2):255-267. doi: 10.2214/AJR.21.27301. Epub 2022 Feb 9. AJR Am J Roentgenol. 2022. PMID: 35138134
-
Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.J Hepatol. 2021 Jun;74(6):1362-1372. doi: 10.1016/j.jhep.2021.01.023. Epub 2021 Jan 26. J Hepatol. 2021. PMID: 33508376
-
Validating the prognostic value of Freiburg index of posttransjugular intrahepatic portosystemic shunt survival score and classic scores in Chinese patients with implantation of transjugular intrahepatic portosystemic shunt.Eur J Gastroenterol Hepatol. 2022 Oct 1;34(10):1074-1080. doi: 10.1097/MEG.0000000000002427. Epub 2022 Aug 24. Eur J Gastroenterol Hepatol. 2022. PMID: 36062497
-
MELD 3.0 Score for Predicting Survival in Patients with Cirrhosis After Transjugular Intrahepatic Portosystemic Shunt Creation.Dig Dis Sci. 2023 Jul;68(7):3185-3192. doi: 10.1007/s10620-023-07834-3. Epub 2023 Jan 30. Dig Dis Sci. 2023. PMID: 36715817
-
Predictive Accuracy Comparison of Prognostic Scoring Systems for Survival in Patients Undergoing TIPS Placement: A Systematic Review and Meta-analysis.Acad Radiol. 2024 Sep;31(9):3688-3710. doi: 10.1016/j.acra.2023.10.050. Epub 2023 Nov 23. Acad Radiol. 2024. PMID: 38000922
Cited by
-
Shunt dysfunction and mortality after transjugular intrahepatic portosystemic shunt (TIPS) in patients with portal hypertension.Insights Imaging. 2024 Aug 7;15(1):193. doi: 10.1186/s13244-024-01768-8. Insights Imaging. 2024. PMID: 39112682 Free PMC article.
-
External validation of the modified CTP score based on ammonia to predict survival in patients with cirrhosis after TIPS placement.Sci Rep. 2024 Jun 16;14(1):13886. doi: 10.1038/s41598-024-64793-z. Sci Rep. 2024. PMID: 38880817 Free PMC article.
-
Prognostic Performance of Model for End-Stage Liver Disease (MELD) 3.0 for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation.Cardiovasc Intervent Radiol. 2025 Jul 14. doi: 10.1007/s00270-025-04116-5. Online ahead of print. Cardiovasc Intervent Radiol. 2025. PMID: 40653531
-
Survival prediction using the Freiburg index of post-TIPS survival (FIPS) in critically ill patients with acute- on chronic liver failure: A retrospective observational study.Front Med (Lausanne). 2022 Dec 22;9:1042674. doi: 10.3389/fmed.2022.1042674. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36619640 Free PMC article.
-
The unwell patient with advanced chronic liver disease: when to use each score?BMC Med. 2025 Jul 9;23(1):413. doi: 10.1186/s12916-025-04185-w. BMC Med. 2025. PMID: 40629399 Free PMC article. Review.
References
-
- Lee BT, Yang AH, Urban S et al. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures. Eur J of Gastroenterol Hepatol. 2021;33:541–546. 10.1097/MEG.0000000000001760. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials